ArticleBiomedicines2023

The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.

Alexander A Berezin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.